Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bast

Showing results (371-380 of 560) with videos related to

Pageof 56
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|April 12, 2012
Programmable bio-nano-chip systems for serum CA125 quantification: toward ovarian cancer diagnostics at the point-of-careArchana Raamanathan, Glennon W Simmons, Nicolaos Christodoulides, et al.
Cancer Research|October 1, 1988
Clinical trials with human tumor necrosis factor: in vivo and in vitro effects on human mononuclear phagocyte functionP R Conkling, C C Chua, P Nadler, et al.
Breast Cancer Research and Treatment|January 1, 1996
Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell supportW A Franklin, E J Shpall, P Archer, et al.
Bone Marrow Transplantation|February 1, 1991
Immunomagnetic purging of breast cancer from bone marrow for autologous transplantationE J Shpall, R C Bast, W T Joines, et al.
Journal of Geriatric Oncology|February 24, 2019
Potentially inappropriate medications defined by STOPP criteria in older patients with breast and colorectal cancerMeghan S Karuturi, Holly M Holmes, Xiudong Lei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 1991
4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trialE J Shpall, R B Jones, R C Bast, et al.
Human Molecular Genetics|April 1, 1994
A novel gene encoding a B-box protein within the BRCA1 region at 17q21.1I G Campbell, H M Nicolai, W D Foulkes, et al.
Cancer Research|March 1, 1983
Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvumR C Bast, J S Berek, R Obrist, et al.
Plos One|July 26, 2012
Modulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancerXiao-Feng Le, Maria I Almeida, Weiqun Mao, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 22, 2024
A novel SIK2 inhibitor SIC-19 exhibits synthetic lethality with PARP inhibitors in ovarian cancerFang Wang, Xuejiao Yu, Jun Qian, et al.
Pageof 56

Showing results (371-380 of 560) with videos related to

Sort By:
Pageof 56
Cancer Prevention Research (Philadelphia, Pa.)|April 12, 2012
Programmable bio-nano-chip systems for serum CA125 quantification: toward ovarian cancer diagnostics at the point-of-careArchana Raamanathan, Glennon W Simmons, Nicolaos Christodoulides, et al.
Cancer Research|October 1, 1988
Clinical trials with human tumor necrosis factor: in vivo and in vitro effects on human mononuclear phagocyte functionP R Conkling, C C Chua, P Nadler, et al.
Breast Cancer Research and Treatment|January 1, 1996
Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell supportW A Franklin, E J Shpall, P Archer, et al.
Bone Marrow Transplantation|February 1, 1991
Immunomagnetic purging of breast cancer from bone marrow for autologous transplantationE J Shpall, R C Bast, W T Joines, et al.
Journal of Geriatric Oncology|February 24, 2019
Potentially inappropriate medications defined by STOPP criteria in older patients with breast and colorectal cancerMeghan S Karuturi, Holly M Holmes, Xiudong Lei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 1991
4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trialE J Shpall, R B Jones, R C Bast, et al.
Human Molecular Genetics|April 1, 1994
A novel gene encoding a B-box protein within the BRCA1 region at 17q21.1I G Campbell, H M Nicolai, W D Foulkes, et al.
Cancer Research|March 1, 1983
Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvumR C Bast, J S Berek, R Obrist, et al.
Plos One|July 26, 2012
Modulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancerXiao-Feng Le, Maria I Almeida, Weiqun Mao, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 22, 2024
A novel SIK2 inhibitor SIC-19 exhibits synthetic lethality with PARP inhibitors in ovarian cancerFang Wang, Xuejiao Yu, Jun Qian, et al.
Pageof 56